GLP-1/GIP/GCG RT (GLP-3) synthetic triple agonist designed for advanced metabolic research and multi-pathway incretin studies. Our GLP-1/GIP/GCG RT provides scientists with high-purity triple receptor agonist that activates GIP, GLP-1, and GCG receptors for comprehensive neuroendocrine investigations.
Product Specifications
- Molecular Weight: 5,486.2 Da
- Chemical Formula: C₂₄₉H₃₇₉N₆₅O₇₅
- Structure: Triple GIP/GLP-1/GCG receptor agonist with C20 fatty diacid chain
- Purity: 99% minimum via third-party testing
- Mechanism: Balanced activity across all three hormone receptors
Research Applications
This triple receptor agonist enables comprehensive laboratory investigations including:
- Multi-pathway metabolic regulation research through integrated hormone receptor activation
- Complex neuroendocrine signaling studies examining GIP/GLP-1/GCG crosstalk
- Energy expenditure mechanism investigations using triple-pathway activation models
- Glucose homeostasis pathway research through complementary receptor signaling
- Cellular energy metabolism studies examining synergistic hormone interactions
Molecular Mechanism
This research compound demonstrates balanced activity across GIP, GLP-1, and GCG receptors, creating a unique signaling profile that regulates glucose homeostasis, energy expenditure, and satiety signals. The triple-receptor engagement activates complementary pathways that provide researchers with opportunities to study complex metabolic integration and receptor pharmacology dynamics.
Laboratory Protocols
- Store lyophilized powder at -20°C
- Reconstitution: Bacteriostatic water recommended for research applications
- Reconstituted solutions store at 2-8°C
- Protect from light and oxidizing agents
- Follow standard peptide handling protocols
Quality Assurance
Every batch undergoes rigorous third-party testing, ensuring molecular weight verification, purity confirmation, and bioactivity screening with complete Certificate of Analysis documentation.
For research purposes only. Not for human consumption or medical use.
